All Comments by Fred Van Leuven

  1. Axonal Transport Not Bothered by Tau Elevation In Vivo
  2. Imaging Tau and Caspases, Aβ’s Synaptic Effects
  3. Enabling Technologies for Alzheimer Disease Research: Seventh Bar Harbor Workshop, 2007, Part 5
  4. Hot Stuff—PIB News From the Pacific Rim
  5. First Crystal Structure of Monoclonal Antibody Binding to Aβ
  6. Alzhemed Tangles with Tau, Too
  7. Single molecule profiling of tau gene expression in Alzheimer's disease.
  8. The secreted beta-amyloid precursor protein ectodomain APPs alpha is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice.
  9. Sporadic cerebral amyloid angiopathy is not a frequent cause of spontaneous brain hemorrhage.
  10. Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation.
  11. How Now, Phospho-tau? Sparing Synapses, Messing with Microtubules
  12. Gain or Loss of Function—Time to Shake up Assumptions on γ-Secretase in Alzheimer Disease?
  13. Early Events in AD Mice as Targets for Therapy
  14. The neuropeptide PACAP promotes the alpha-secretase pathway for processing the Alzheimer amyloid precursor protein.
  15. SfN: Return of the Other—Tau Is Back, Part 4